In a time of increased challenges and significant opportunities for the healthcare system, GSK Greece is prioritizing patient access to vaccines and innovative treatments, emphasizing the power of scientific innovation and prevention. Lizzie Champion, the President and General Director of the company, outlines the organization’s goals and its plans to position Greece as a center for clinical research in her interview with To Vima. Champion discusses her personal motivation for her career, her strategic vision, and the role Greece plays within the company’s global ecosystem.

Champion, who has over 20 years of experience in the pharmaceutical industry, emphasizes the transformation of GSK in Greece, particularly in light of current healthcare challenges. Her leadership is focused on strategic goals that align with the company's commitment to innovation and patient care. With the growing importance of preventive healthcare, GSK intends to leverage Greece's potential to contribute significantly to clinical research and healthcare advancements.

The company’s initiative underscores the critical intersection of healthcare, innovation, and research, which is particularly relevant in the context of emerging health challenges intensified by the pandemic. By positioning Greece as a hub for clinical research, GSK aims to enhance its operational efficiency and ultimately provide better healthcare solutions both domestically and internationally. Champion's leadership and vision are central to these ambitious goals, indicating a proactive approach to tackling healthcare issues through innovative strategies and a commitment to prevention.